The Metabolic Response to Reduced Branched-chain Amino Acids in Humans — SOAR  

Obesity Clinical Trial

Official title: The Metabolic Response to Reduced Branched-chain Amino Acids in Humans

Status Completed

Clinical Trial Summary

Branched-chain amino acids (BCAAs) are essential nutrients that the body obtains from proteins found in food, especially meat, diary products, and legumes. Data from rodent studies suggest that reduction of dietary BCAAs will promote fat mass loss and improved control of blood glucose. The purpose of this study is to test if reduction of dietary BCAAs without reducing calorie intake will lead to similar metabolic benefits in humans. Here the investigators test the feasibility of reducing dietary BCAAs using BCAA-free meal replacement beverages for two months.

Clinical Trial Description

This study, which will be completed over three months, involves replacing two meals a day with meal replacement beverages for two months, with a one month follow-up visit. These beverages will be made up by subjects using either a complete protein powder or BCAD2, a BCAA-free medical food. Participants will complete food diaries at baseline and at one month intervals during the study, and compliance will be assessed via food diaries, weekly telephone contact, and measuring returned food powder. ;

Related Conditions & MeSH terms

• Diabetes
• Insulin Resistance
• Obesity

• NCT number: NCT03239717
• Study type: Interventional
• Source: University of Wisconsin, Madison
• Status: Completed
• Phase: N/A
• Start date: November 28, 2017
• Completion date: July 16, 2021